State Street SPDR S&P Biotech ETF XBI
ASignal view: Not yet rated
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
Fund facts
Category
Health
Expense ratio
0.35%
AUM
$9.63B
Sector breakdown
Asset allocation
Signal overlay
ASignal covers 2 of 10 top holdings. Weighted across covered holdings:
BULLISH 0% · NEUTRAL 100% · BEARISH 0%
Top holdings
| Symbol | Name | Weight | ASignal |
|---|---|---|---|
| APGE | Apogee Therapeutics Inc | 1.6% | Neutral |
| ORKA | Oruka Therapeutics Inc | 1.5% | Not covered |
| DNTH | Dianthus Therapeutics Inc | 1.4% | Not covered |
| ERAS | Erasca Inc | 1.4% | Not covered |
| TWST | Twist Bioscience Corp | 1.4% | Neutral |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.3% | Not covered |
| SYRE | Spyre Therapeutics Inc | 1.3% | Not covered |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.3% | Not covered |
| CGON | CG Oncology Inc | 1.3% | Not covered |
| PTGX | Protagonist Therapeutics Inc | 1.3% | Not covered |